Zhang W, Mu H, Zhang Q, Patel NB, Fogler WE, Magnani JL, Andreeff M
Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies
Side effects were more common in the oral semaglutide group (16.7%) than in the injection group (4.9%)
The UKPDS also showed that Postprandial (1-2 hours after eating) glucose is a better indicator of glycemic control than fasting glucose levels 9
The food noisethe constant thoughts about eating, the cravings, the planningcomes roaring back
There are medications that work, but theyre priced for profits, not patients. Indeed, obesity is a pervasive health issue, and not just in the U.S